WE wish to express our support for the recent statements made by Health Minister Datuk Seri Dr Dzulkefly Ahmad regarding the National Generic Medicines Framework. The announcement that Malaysia has achieved over RM900mil in savings through the “generic first policy” over the past two years is significant for our national healthcare sustainability.
As pharmacy educators, we must emphasise that the cornerstone of this framework is scientific parity, where all medicines are evaluated based on scientific evidence from regulatory approval, bioequivalence (BE) studies and ongoing monitoring.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
